Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer

Bell RJ, Fradkin P, Parathithasan N, Robinson PJ, Schwarz M, Davis SR

(2013), Breast, 22(5), 980-5

Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia

Bell RJ, Robinson PJ, Barallon R, Fradkin P, Schwarz M, Davis SR

(2013), Support Care Cancer, 21(7), 2017-24

Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis

Bell RJ, Schwarz M, Fradkin P, Robinson PJ, Davis SR

(2013), Menopause, 20(7), 721-6

Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis

Bell RJ, Fradkin P, Schwarz M, Davis SR

(2013), Menopause, 20(1), 15-21

Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009

Wong N, Haydon A, Kemp W, Wijeratne P, Roberts S

(2013), Intern Med J, 43(2), 197-203

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

Vickers MM, Karapetis CS, Tu D, O'Callaghan CJ, Price TJ, Tebbutt NC, Van Hazel G, Shapiro JD, Pavlakis N, Gibbs P, Blondal J, Lee U, Meharchand JM, Burkes RL, Rubin SH, Simes J, Zalcberg JR, Moore MJ, Zhu L, Jonker DJ

(2013), Ann Oncol, 24(4), 953-60

Use of imaging in surveillance of women with early stage breast cancer

Bell RJ, Schwarz M, Fradkin P, Davis SR

(2013), ANZ J Surg, 83(3), 129-34

Management of advanced gastric cancer

Price TJ, Shapiro JD, Segelov E, Karapetis CS, Pavlakis N, Van Cutsem E, Shah MA, Kang YK, Tebbutt NC

(2012), Expert Rev Gastroenterol Hepatol, 6(2), 199-208

Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia

Bell RJ, Robinson PJ, Fradkin P, Schwarz M, Davis SR

(2012), Breast, 21(3), 394-400

Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia

Bell RJ, Lijovic M, Fradkin P, Schwarz M, Davis SR

(2012), Support Care Cancer, 20(4), 783-9

The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

Goldstein D, Spry N, Cummins MM, Brown C, van Hazel GA, Carroll S, Selva-Nayagam S, Borg M, Ackland SP, Wratten C, Shapiro J, Porter IW, Hruby G, Horvath L, Bydder S, Underhill C, Harvey J, Gebski VJ; Australasian Gastro-Intestinal Trials Group

(2012), Br J Cancer, 106(1), 61-9

Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal

Cherk MH, Francis P, Topliss DJ, Bailey M, Kalff V

(2012), Clin Endocrinol, 76(5), 734-40

Adjuvant trastuzumab in HER2-positive breast cancer

Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cance

(2011), N Engl J Med, 365(14), 1273-83

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX

Aebi S, Sun Z, Braun D, Price KN, Castiglione-Gertsch M, Rabaglio M, Gelber RD, Crivellari D, Lindtner J, Snyder R, Karlsson P, Simoncini E, Gusterson BA, Viale G, Regan MM, Coates AS, Goldhirsch A

(2011), Ann Oncol, 22(9), 1981-7

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer

Karlsson P, Sun Z, Braun D, Price KN, Castiglione-Gertsch M, Rabaglio M, Gelber RD, Crivellari D, Collins J, Murray E, Zaman K, Colleoni M, Gusterson BA, Viale G, Regan MM, Coates AS, Goldhirsch A

(2011), Ann Oncol, 22(10), 2216-26

An exploration of the dynamics and influences upon second medical opinion consultations in cancer care

Philip J, Gold M, Schwarz M, Komesaroff P

(2011), Asia-Pac J Clin Onco, 7(1), 41-6

18F-fluorodeoxyglucose positron emission tomography-positive sarcoidosis after chemoradiotherapy for Hodgkin's disease: a case report

Cherk MH, Pham A, Haydon A

(2011), J Med Case Rep, 5, 247

Investigation of the safety of irreversible electroporation in humans

Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, Roberts S, Evans P, Ball C, Haydon A

(2011), J Vasc Interv Radiol, 22(5), 611-21

Current opinion on optimal treatment choices in first-line therapy for advanced or metastatic colorectal cancer: report from the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008

Price TJ, Tebbutt NC, Karapetis CS, Segelov E, Pavlakis N, Cunningham D, Sobrero AF, Haller DG, Shapiro JD

(2010), Clin Colorectal Cancer, 9(1), 8-14

Evaluation of the exposure equivalence of oral versus intravenous temozolomide

Diez BD, Statkevich P, Zhu Y, Abutarif MA, Xuan F, Kantesaria B, Cutler D, Cantillon M, Schwarz M, Pallotta MG, Ottaviano FH

(2010), Cancer Chemother Pharmacol, 65(4), 727-34

5 6 7 8 9